Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Garg D, Muthu V, Sehgal IS, Ramachandran R, Kaur H, Bhalla A et al (2021) Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature. Mycopathologia 186:289–98
2. Kumar M, Sarma DK, Shubham S, Kumawat M, Verma V, Singh B et al (2021) Mucormycosis in COVID-19 pandemic: risk factors and linkages. Curr Res Microb Sci. 2:100057
3. Raut A, Huy NT (2021) Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave? Lancet Respir Med 9(8):e77. https://doi.org/10.1016/S2213-2600(21)00265-4
4. Singh AK, Singh R, Joshi SR, Misra A (2021) Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 15:102146
5. Ahmed E, Abou-Bakr A, Hussein RR, El-Gawish AA, Ras A, bakr E, Ghalwash DM (2021) Oral mucormycosisin post-COVID-19 patients: a case series. Oral Dis. https://doi.org/10.1111/ODI.13973